phy906
Botanicalexperimental
Clinical trial activity
5 trials · 10 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2002 (NCT00036517)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- phy906
- phy906
- phy 906
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04000737 | Phase 2 | Aug 15, 2019 | Memorial Sloan-Kettering Cancer Center, Taipei Medical University, Yiviva Inc. |
| NCT01666756 | Phase 1 | May 6, 2013 | City of Hope National Medical Center, National Cancer Institute (NCI) |
| NCT00411762 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2006 | National Comprehensive Cancer Network, PhytoCeutica, Roche, Yale University |
| NCT00076609 | Phase 1/Phase 2 (Phase 2) | Oct 1, 2003 | PhytoCeutica |
| NCT00036517 | Phase 1/Phase 2 (Phase 2) | Feb 1, 2002 | Inveresk Research, PhytoCeutica |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (10)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| PhytoCeutica | For profit | 3 | 2 | 1 | 2002 |
| City of Hope National Medical Center | Academic/Hospital | 1 | 1 | 1 | 2013 |
| Inveresk Research | For profit | 1 | 0 | 1 | 2002 |
| Memorial Sloan-Kettering Cancer Center | Academic/Hospital | 1 | 0 | 1 | 2019 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2013 |
| National Comprehensive Cancer Network | Academic/Hospital | 1 | 0 | 1 | 2006 |
| Roche | For profit | 1 | 0 | 1 | 2006 |
| Taipei Medical University | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Yale University | Academic/Hospital | 1 | 1 | 1 | 2006 |
| Yiviva Inc. | For profit | 1 | 1 | 1 | 2019 |
10 organizations
Page 1 / 1